One-pot a-arylation of b-carboline with indole and naphthol derivatives by Sas, Judit et al.
Send Orders for Reprints to reprints@benthamscience.ae 
 Journal Name, Year, Volume 1 
 XXX-XXX/14 $58.00+.00 © 2014 Bentham Science Publishers 
One-pot α-arylation of β-carboline with indole and naphthol derivatives 
Judit Sas, István Szatmári and Ferenc Fülöp* 
 
Institute of Pharmaceutical Chemistry and Research Group for Stereochemistry, Hungarian Academy of Sciences, 
University of Szeged, H-6720 Szeged, Eötvös u. 6, Hungary 
Abstract: 4,9-Dihydro-3H-β-carboline and 6-methoxy-4,9-dihydro-3H-β-carboline were subjected to catalyst-free one-
pot α-arylation with 1 or 2-naphthol, 6-hydroxyquinoline or 5-hydroxyisoquinoline as N-containing analogues via direct 
aza-Friedel-Crafts reactions. The procedure was then extended to other electron-rich aromatic compounds, such as indole 
or indole-2-carboxylic acid, to yield new indole γ-amino acid derivatives containing β-carboline skeleton. All the 
reactions were performed both under neat conditions and with microwave irradiation. The reaction of 2,3,4,9-tetrahydro-
1H-pyrido[3,4-b]indole and benzaldehyde with 1-naphthol as nucleophile led to the formation of the N-alkylated 
compound as a single product, whereas the reaction with 2- resulted in the two possible α-arylated/N-alkylated products, 
in a ratio depending on the reaction conditions. 
Keywords: β-Carboline • Indole • Naphthol • Aza-Friedel-Crafts alkylation • modified Mannich reaction • Microwave reaction
INTRODUCTION 
 The β-carboline skeleton is present in numerous naturally 
occurring alkaloids, which often exhibit biological activity. 
Natural β-carboline-containing compounds, such as the 
harman family, including the eudistomines and manzamines, 
or the canthines, with an additional fused cycle, initially 
attracted interest because of their potent psychoactive and 
hallucinogenic abilities [1]. Harmane, harmine and 
harmaline β-carboline alkaloids, e.g. (+)-harmicine, exhibit a 
wide range of pharmacological properties, including 
antimicrobial and anti-HIV activities [1-3]. Among more 
complex β-carboline alkaloids, yohimbine is an antagonist of 
α2-receptors located both presynaptically and postsynap-
tically on noradrenergic neurons, while reserpine is known 
as an antipsychotic and antihypertensive drug [3]. Moreover, 
synthetic β-carbolines display antimalarial [4], antiparasitic 
[4] and antineoplasic [5] activity, while certain β-carbolines 
inhibit TNF-α [6] or MK2 [7]. Tricyclic β-carboline 
derivatives have been found to be mGluR1 antagonists [8], 
and bromo-substituted tetrahydro-β-carbolines have been 
described as neurotoxic agents [9]. 
 Product of these compounds demands efficient synthetic 
methodologies, for the construction of the heterocyclic 
system and its functionalization. The synthetic strategies for 
the synthesis of condensed β-carbolines mainly start from 
the partially saturated β-carbolines trough 1,3-dipolar 
cycloaddition [10], coupling with isatoic anhydride [11], 
reaction with Mannich bases [12], the inverse-electron-
demand imino Diels-Alder reaction with chromone-derived 
dienes [13], or reaction with salicyl chloride [14].       
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On the other hand, the syntheses of new β-carboline-fused 
heterocycles have been achieved through ring-closing 
metathesis or its combination with the Diels-Alder reaction 
[15-16]. 
 We earlier described the aza-Friedel-Crafts alkylations of 
electron-rich aromatic compounds such as 1 or 2-naphthol 
[17], 3-hydroxyisoquinoline, 4-hydroxyquinoline, 5-hyd-
roxyisoquinoline, 6-hydroxyquinoline, 8-hydroxy-quinoline 
or 2-methyl-8-hydroxyquinoline [18] with 3,4-dihydro-
isoquinoline. The possibilities were then extended by using 
indole or indole-2-carboxylic acid as electron-rich aromatic 
compounds and 3,4-dihydroisoquinolines, 4,6-dihydro-3H-
benz[c]azepine or 6,7-dihydrothieno[2,3-c]pyridine as cyclic 
imines [19]. 
RESULTS AND DISCUSSIONS 
 Our present aim was to examine further possibilities of 
the aza-Friedel-Crafts alkylation of electron-rich aromatic 
compounds (naphthols, N-containing naphthol analogues or 
indole derivatives) with 4,9-dihydro-3H-β-carboline as 
cyclic imine substrate. 
 The reaction between 4,9-dihydro-3H-β-carboline (1a) 
[14] and 2-naphthol (2a) was first examined under neat 
conditions at 80 ºC. After 10 h, the desired product 3a was 
isolated in a yield of 48% (Table 1). When the temperature 
was increased (100 ºC) and/or a longer reaction time was 
applied, the starting compounds underwent decomposition. 
The reaction was therefore carried out with microwave 
(MW) agitation. After 2 h at 100 ºC under these conditions, 
addition of diethyl ether led to the isolation of 1-(2,3,4,9-
tetrahydro-1H-pyrido[3,4-b]indol-1-yl)naphthalen-2-ol (3a) 
in a yield of 75% (Table 1).  
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 1a was next reacted with 1-naphthol (5a). After 8 h, at 80 
ºC, the desired 2-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-
1-yl)naphthalen-1-ol (6a) was isolated in a yield of 61%. 
Through the use of microwave irradiation, the reaction could 
be accelerated (reaction time 1.5 h), while the yield was 
improved to 80% at 100 ºC (Table 1). 
 Recent developments have included the successful 
application of N-containing naphthol analogues as electron-
rich aromatic compounds in the modified Mannich reaction 
[20] and in the aza-Friedel-Crafts reaction [18]. Two 
representative N-containing naphthol analogues (6-
hydroxyquinoline (2b) as 2-naphthol, and 5-hydroxy-
isoquinoline (5b) as 1-naphthol analogue) were selected to 
examine their reactivities towards 1a. When 1a and 2b or 5b 
were subjected to classical heating  under neat conditions, 
the desired 5-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-
yl)quinolin-6-ol (4a) and 6-(2,3,4,9-tetrahydro-1H-pyrido-
[3,4-b]indol-1-yl)isoquinolin-5-ol (7a) were isolated in 
moderate yields (57% for 4a, 43% for 7a, Table 1). On the 
use of MW agitation, the reaction times were decreased, but 
the yields were not improved significantly (68% for 4a, 63% 
for 7a, Table 1).  
 When naphthol derivatives (2a, 2b, 5a, 5b) were reacted 
with 6-methoxy-β-carboline (1b) [14], the desired amino-
naphthols (3b, 4b, 6b, 7b) were isolated. The reaction 
conditions and yields are presented in Table 1. 
 
Table 1. Reaction conditions for the synthesis of 3a, 3b, 4a, 4b, 6a, 6b, 7a and 7b from 1- or 2-naphthol or their N-containing 
analogues. 
 
 
 
 
 
 
 
 
 
 
Product Neat conditions Yield (%) MW agitation Yield (%) 
3a 80 οC, 10 h 48 100 οC, 2 h 75 
3b 80 οC, 12 h 39 100 οC, 3 h 65 
4a 80 οC, 5 h 57 100 οC, 0.5 h 68 
4b 80 οC, 10 h 43 100 οC, 2 h 56 
6a 80 οC, 8 h 61 100 οC, 1.5 h 80 
6b 80 οC, 12 h 41 100 οC, 2 h 64 
7a 80 οC, 6 h 43 100 οC, 1.5 h 63 
7b 80 οC, 4 h 63 100 οC, 1 h 82 
 
 Many natural and synthetic indoles are used as 
pharmaceuticals [21], and we earlier prepared  a number of 
3 substitued indoles through the catalyst-free coupling of 
indoles and cyclic imines [19]. This prompted us to study 
the reactions between the above β-carbolines and indoles. 
 When indole (8) was reacted under solvent-free 
conditions with the partially unsaturated 1a at 80 οC, 3-
(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)indole (9a) 
was isolated in a yield of 35%. Under MW agitation at 100 
οC, the reaction time could be decreased from 4 h to 30 
min (Table 2). The synthesis of 9a has already been 
achieved [22-24] from 1H-indole-3-ethanamine and 1H-
indole-3-carboxaldehyde via Pictet-Spengler condensation. 
The main advantage of our method is the application of 
indole instead of indole-3-carboxaldehyde. The direct α-
arylation of partially saturated β-carbolines with electron-
rich aromatic compounds therefor opens up a new area for 
this reaction. As an example, the reaction between 1a and 
indole-2-carboxylic acid (10) was examined. The optimum 
reaction conditions were found to be 80 οC for 4 h on 
classical heating, and 100 οC for 20 min on MW 
irradiation. The desired new indole γ-amino acid 11a was 
isolated in a yields of 73% (classical heating) and 91% 
(MW). Extension of the reaction by using 1b as cyclic 
imine and 8 or 10 as electron-rich aromatic compound led 
to the desired 3-(6-methoxy-2,3,4,9-tetrahydro-1H-
pyrido[3,4-b]indol-1-yl)indole derivatives (9b and 11b) in 
good yields (see Table 2). 
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Table 2. Reaction conditions for the synthesis of 9a, 9b, 11a, and 11b from indole or indole-2-carboxylic acid 
 
 
 
 
 
 
 
 
Product Neat conditions Yield (%) MW agitation Yield (%) 
9a 80 οC, 4 h 35 100 οC, 30 min 83 
9b 80 οC, 6 h 31 100 οC, 1 h 77 
11a 80 οC, 4 h 73 100 οC, 20 min 91 
11b 80 οC, 5 h 54 100 οC, 0.5 h 87 
 
 In recent investigations, aminonaphthols prepared via 
the three-component modified Mannich reaction proved to 
be excellent model compounds for study of the α-
arylation/N-alkylation of cyclic amines [25-27]. Whereas 
the aminoalkylation of 2-naphthol with 1,2,3,4-
tetrahydroisoquinoline in the presence of benzaldehyde led 
to the parallel N-alkylation and redox α-arylation of the 
tetrahydroisoquinoline in a ratio of 4:1, the corresponding 
reaction of 1-naphthol with 1,2,3,4-tetrahydroisoquinoline 
furnised the N-alkylated compound as a single product, 
illustrating that the reaction route depends on the naphthol 
[28].  It also depends on the nature of the cyclic amine, and 
we therefore performed a systematic investigation of the 
reactions of 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole 
with 1- or 2-naphthol as nucleophile in the presence of 
benzaldehyde. Repeated information should not be 
reported in the text of an article. A calculation section must 
include experimental data, facts and practical development 
from a theoretical perspective.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Synthesis of aminonaphthols 14-17. Reaction conditions: i) 60 οC, neat; ii) 80 οC, neat; iii) 60 οC, neat, MW; iv) 80 
οC, neat, MW   
N
H
NH
NH
R
N
H
NH
NH
COOH
R
N
H
N
R N
H
COOH
N
H
R = H: 9a
R = OMe: 9b
8 10
R = H: 11a
R = OMe: 11b
R = H: 1a
R = OMe: 1b
OH
OH
OH
N
OH N
N
N
OH
OH
NH
NH
NH
NH
NH
NH
15
14
17
16
12
6a3a
BzBr BzBr
i-iv i-iv
v v
PhCHO i -iv
N
NH
13a
N
NH
13b
+
+
5a5b
Send Orders for Reprints to reprints@benthamscience.ae 
 Journal Name, Year, Volume 4 
 XXX-XXX/14 $58.00+.00 © 2014 Bentham Science Publishers 
 2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indole (12) [29], 2-
naphthol (2a) and benzaldehyde were reacted (Scheme 1) 
neat under different reaction conditions (i: 60 οC, classical 
heating; ii: 80 οC, classical heating; iii: 60 οC, MW; iv: 80 
οC, MW). For the systematic investigation of this reaction, 
the possible α-arylated product 15 was synthetized from 1-
(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)naphthalen-
2-ol (3a) and benzyl bromide (Scheme 1). The formation 
of the possible products (14 and 15) and the conversions of 
the reactions (i-iv) were followed by NMR spectroscopy. 
The reactions were found to be complete after 7 h (i), 5 h 
(ii) and 3 h (iii and iv), respectively. The crude reaction 
mixture in all cases indicated the presence of both possible 
products 14 and 15. The ratio 14:15 was found to be 4:1 for 
i and iii, and 2:1 for ii. In the case of iv (80 οC, MW), the 
ratio was not constant during the reaction. After 0.5 h it 
was 1:0.8, and at the end of the reaction (3 h) a ratio of 
1:2.5 was assumed. This means that the formation of 13b is 
more preferable a 80 οC than at 60 οC. It can also be 
assumed that the product ratio depends on the heating 
technique: classical heating or MW agitation.  
 To examine the behaviour of 1-naphthol in this 
reaction, 5a was reacted with 2,3,4,9-tetrahydro-1H-
pyrido[3,4-b]indole (12) in the presence of benzaldehyde, 
when the possible products obtained through the α-
arylation/N-alkylation of 12 were 16 and 17 (Scheme 1). 
For a systematic study of this reaction, the α-arylated 
product was prepared by the reaction of 2-(2,3,4,9-
tetrahydro-1H-pyrido[3,4-b]indol-1-yl)naphthalen-1-ol 
(6a) and benzyl bromide. 
When 1-naphthol (5a), 2,3,4,9-tetrahydro-1H-pyrido[3,4-
b]indole (12) and benzaldehyde were reacted under 
reaction conditions i-iv, the signals of the crude products 
indicated only the formation of 16. This proved to be 
independent of temperature (60 οC or 80 οC) and of the 
reaction conditions (classical or MW heating). 
CONCLUSION 
 A simple synthesis of 1-hydroxynaphthyl-2,3,4,9-
tetrahydro-1H-pyrido[3,4-b]indoles  has been developed, 
involving the reaction of 4,9-dihydro-3H-β-carboline and 
1- or 2-naphthol. The synthetic pathway was extended to 
the preparation of 5-(2,3,4,9-tetrahydro-1H-pyrido[3,4-
b]indol-1-yl)quinolin-6-ol or 6-(2,3,4,9-tetrahydro-1H-
pyrido[3,4-b]indol-1-yl)isoquinolin-5-ol from N-containing 
naphthol analogues (quinolin-6-ol or isoquinolin-5-ol) and 
of 1-(1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-
b]indole and 3-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-
1-yl)-1H-indole-2-carboxylic acid from indole and indole-
2-carboxylic acid. The reactions were optimized by the use 
of MW agitation, which led to the desired compounds in 
good yields. The synthetic applicability of the β-carboline 
substrate was tested by starting from 6-methoxy-4,9-
dihydro-3H-β-carboline and the electron-rich aromatic 
compounds used previously. 
The reaction of 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole 
with 1-naphthol as nucleophile in the presence of 
benzaldehyde proved to be regioselective for the formation 
of the N-alkylated derivative 16 as a single product. With 
2-naphthol as nucleophile, both of the possible N-alkylated 
and α-arylated products 14 and 15 were detected, in a ratio 
depending on the temperature and the heating technique. 
The concluding lines of the article may be presented in a short 
section of conclusion.  
 
EXPERIMENTAL 
 The 1H and 13C NMR spectra were recorded in DMSO 
solutions in 5 mm tubes, at room temperature, with a 
Bruker spectrometer at 400 (1H) and 100.6 (13C) MHz, 
with the deuterium signal of the solvent as the lock and 
TMS as internal standard. Melting points were determined 
on a Hinotek X-4 melting point apparatus. Elemental 
analyses were performed with a Perkin-Elmer 2400 CHNS 
elemental analyser. Merck Kieselgel 60F254 plates were 
used for TLC. The microwave reactions were performed 
with a CEM Discover SP microwave reactor. 
 The starting 4,9-dihydro-3H-β-carboline (1a) and 6-
methoxy-4,9-dihydro-3H-β-carboline (1b) were prepared 
according to a literature method [14].  
 
General method for the synthesis of 3a,b, 4a,b, 6a,b, 
7a,b, 9a,b, 11a and 11b 
0.5 mmol 1a or 1b and 0.5 mmol electron-rich aromatic 
compound (2a, 2b, 5a, 5b, 8 or 10) were placed, in a 10 
mL pressurized reaction vial and the reaction mixture was 
heated in an oil bath or in a CEM Discover SP MW reactor 
under the reaction conditions and yields listed in Tables 1 
and 2. 
 
1-(2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indol-1-yl)naph-
thalen-2-ol (3a)  
Crystallized from Et2O (7 mL), recrystallized from iPr2O 
(10 mL). Beige crystals. Mp: 191-192 °C. 1H NMR: 2.77-
2.86 (1H, m); 2.89-2.99 (1H, m); 3.07-3.16 (1H, m); 3.47-
3.57 (1H, m); 6.17 (1H, s); 6.90-6.97 (2H, m); 6.99 (1H, d, 
J = 8.6 Hz); 7.14-7.19 (1H, m); 7.34 (1H, t, J = 7.5 Hz); 
7.38-7.44 (1H, m); 7.5 (1H, t, J = 7.6 Hz); 7.78 (1H, d, J = 
8.6 Hz); 7.86 (1H, d, J = 8.4 Hz); 8.18 (1H, d, J = 8.8 Hz); 
9.7 (1H, s). 13C NMR: 22.4; 44.2; 52.6; 107.1; 107.6; 
108.0; 112.4; 116.8; 118.2; 119.2; 120.3; 121.3; 123.0; 
123.2; 127.5; 129.0; 129.4; 130.2; 132.0; 133.8; 137.1.  
Anal. Calcd for C21H18N2O: C, 80.23; H, 5.77; N, 8.91. 
Found: C, 80.22; H, 5.78, N, 8.90. 
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1-(6-Methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-
1-yl)naphthalen-2-ol (3b) 
Purified by column chromatography (DCM/MeOH 9:1), 
crystallized from n-hexane (10 mL). Beige crystals. Mp: 
175-176 °C. 1H NMR: 2.72-2.8 (1H, m); 2.84-2.94 (1H, 
m); 3.02-3.12 (1H, m); 3.42-3.50 (1H, m); 3.73 (3H, s); 
6.13 (1H, s); 6.57 (1H, d, J = 8.6 Hz); 6.89 (1H, s); 6.97 
(1H, d, J = 8.7 Hz); 7.03 (1H, d, J = 8.7 Hz); 7.32 (1H, t, J 
= 7.2 Hz); 7.43-7.53 (1H, m); 7.76 (1H, d, J = 8.7 Hz); 
7.83 (1H; d; J = 8.0); 8.15 (1H, d, J = 8.4 Hz); 9.5 (1H, s). 
13C NMR: 21.7; 43.4; 55.4; 99.6; 104.5; 107.0; 110.3; 
112.2; 116.0; 119.5; 121.0; 122.4; 126.7; 127.2; 128.1; 
128.5; 129.4; 131.3; 133.0; 153.1. Anal. Calcd for 
C22H20N2O2: C, 76.72; H, 5.85; N, 8.13. Found: C, 76.77; 
H, 5.84, N, 8.15. 
 
5-(2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indol-1-
yl)quinolin-6-ol (4a) 
Crystallized from Et2O (7 mL), recrystallized from EtOAc 
(10 mL). Beige crystals. Mp: 239-240 °C. 1H NMR: 2.75-
2.84 (1H, m); 2.87-2.99 (1H, m); 3.04-3.16 (1H, m); 3.43-
3.57 (1H, m); 6.14 (1H, s); 6.89-6.97 (2H, m); 7.07-7.14 
(1H, m); 7.21 (1H, d, J = 8.9 Hz); 7.37-7.42 (1H, m); 7.42-
7.48 (1H, m); 7.87 (1H, d, J = 8.9 Hz); 8.59 (1H, d, J = 8.8 
Hz); 8.67-8.71 (1H, m); 9.82 (1H; s). 13C NMR: 22.37; 
44.2; 52.2; 112.2; 114.5; 116.8; 118.3; 119.2; 121.4; 122.4; 
123.5; 127.5; 129.0; 131.2; 131.5; 137.1; 144.1; 147.4; 
157.1.. Anal. Calcd for  C20H17N3O: C, 76.17; H, 5.43; N, 
13.32. Found: C, 76.15; H, 5.45, N, 13.30. 
 
5-(6-Methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-
1-yl)quinolin-6-ol (4b) 
Crystallized from Et2O (7 mL), recrystallized from EtOAc 
(10 mL). Beige crystals. Mp: 221–222 °C. 1H NMR: 2.75-
2.83 (1H, m); 2.87-2.97 (1H, m); 3.05-3.14 (1H, m); 3.45-
3.57 (1H, m); 3.75 (3H, s); 6.57-6.63 (1H, m); 6.91 (1H, s); 
7.01 (1H, d, J = 8.7 Hz); 7.23 (1H, d, J = 8.8 Hz); 7.43-
7.49 (1H, m); 7.88 (1H, m, J = 8.9 Hz);  8.59 (1H, d, J = 
8.5 Hz); 8.68-8.73 (1H, m); 9.65 (1H, s). 13C NMR: 22.42; 
44.2; 52.3; 56.2; 100.6; 108.0; 111.2; 112.8; 115.2; 115.9; 
122.4; 123.5; 127.8; 128.9; 131.2; 131.5; 132.1; 144.1; 
147.4; 153.9; 154.0. Anal. Calcd for  C21H19N3O2 :  C, 
73.03; H, 5.54; N, 12.17. Found: C, 73.01; H, 5.56, N, 
12.15. 
 
2-(2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indol-1-
yl)naphthalen-1-ol (6a) 
Crystallized from Et2O (7 mL), recrystallized from iPr2O 
(10 mL). Light-brown crystals. Mp: 200–201 °C. 1H NMR: 
2.75-2.90 (2H, m); 3.02-3.3 (2H, m); 5.49 (1H, s); 6.93-
7.05 (2H, m); 7.26 (1H, d, J = 7.9 Hz); 7.36 (2H, s); 7.38-
7.48 (3H, m); 7.81 (1H, d, J = 7.8 Hz); 8.06 (1H, d, J = 7.6 
Hz); 10.4 (1H, s). 13C NMR: 22.3; 42.2; 56.8; 108.1; 112.1; 
118.2; 119.0; 119.3; 121.7; 122.7; 125.4; 125.8; 126.8; 
127.5; 127.9; 128.1; 134.3; 134.5; 137.0; 154.2. Anal. 
Calcd for C21H18N2O: C, 80.23; H, 5.77; N, 8.91. Found: 
C, 80.22; H, 5.79, N, 8.89. 
2-(6-Methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-
1-yl)naphthalen-1-ol (6b) 
Purified by column chromatography (DCM/MeOH 9:1), 
crystallized from n-hexane (10 mL). Beige crystals. Mp: 
189-190 °C. 1H NMR: 2.72-2.8 (1H, m); 2.84-2.94 (1H, 
m); 3.02-3.12 (1H, m); 3.42-3.50 (1H, m); 3.73 (3H, s); 
6.13 (1H, s); 6.57 (1H, d, J = 8.6 Hz); 6.89 (1H, s); 6.97 
(1H, d, J = 8.7 Hz); 7.03 (1H, d, J = 8.7 Hz); 7.32 (1H, t, J 
= 7.2 Hz); 7.43-7.53 (1H, m); 7.76 (1H, d, J = 8.7 Hz); 
7.83 (1H; d; J= 8.0 Hz); 8.15 (1H, d, J= 8.4 Hz); 9.5 (1H, 
s). 13C NMR: 21.7; 43.4; 55.4; 99.6; 104.5; 107.0; 110.3; 
112.2; 116.0; 119.5; 121.0; 122.4; 126.7; 127.2; 128.1; 
128.5; 129.4; 131.3; 133.0; 153.1. Anal. Calcd for 
C22H20N2O2: C, 76.72; H, 5.85; N, 8.13. Found: C, 76.74; 
H, 5.84, N, 8.14. 
 
6-(2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indol-1-yl)iso-
quinolin-5-ol (7a) 
Crystallized from Et2O (7 mL), recrystallized from 
iPr2O/EtOAc (1:3; 12 mL). Light-brown crystals. Mp: 229-
230 °C. 1H NMR: 2.78-2.85 (2H, m); 3.02-3.12 (1H, m); 
3.19-3.27 (1H, m); 3.76 (3H, s); 5.55 (1H, s); 6.93-6.98 
(1H, m); 6.99-7.04 (1H, m); 7.25 (1H, d, J = 8.1 Hz); 7.43 
(1H, d, J = 7.6 Hz); 7.48-7.54 (2H, m); 7.81-7.85 (1H, m); 
8.36-8.40 (1H, m); 9.19 (1H, s) 10.47 (1H, s). 13C NMR: 
22.1; 41.9; 56.6; 108.3; 112.1; 115.7; 117.3; 118.6; 119.4; 
121.9; 123.1; 127.4; 128.2; 129.4; 129.6; 133.4; 137.0; 
142.5; 152.6; 153.8. Anal. Calcd for  C20H17N3O: C, 76.17; 
H, 5.43; N, 13.32. Found: C, 76.18; H, 5.42, N, 13.34. 
 
6-(6-Methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-
1-yl)isoquinolin-5-ol (7b) 
Crystallized from Et2O (7 mL), recrystallized from 
iPr2O/EtOAc (1:3; 12 mL). Beige crystals. Mp: 222-223 
°C. 1H NMR: 2.77-2.84 (2H, m); 3.03-3.12 (1H, m); 3.20-
3.28 (1H, m); 3.76 (3H, s); 5.54 (1H, s); 6.68 (1H, d, J = 
8.9 Hz); 6.94 (1H, s); 7.15 (1H, d, J = 8.7 Hz); 7.49-7.56 
(2H, m); 7.82-7.88 (1H, m); 8.37-8.43 (1H, m); 9.20 (1H, 
s); 10.31 (1H, s). 13C NMR:22.1; 41.9; 56.3; 56.7; 100.9; 
108.2; 111.7; 112.7; 115.7; 117.3; 123.1; 127.7; 128.2; 
129.3; 132.1; 134.1; 142.5; 152.6; 153.8; 154.1. Anal. 
Calcd for  C21H19N3O2: C, 73.03; H, 5.54; N, 12.17. Found: 
C, 73.05; H, 5.56, N, 12.18. 
 
3-(2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indol-1-yl)indole 
(9a) 
Crystallized from n-hexane/EtOAc (9:1; 7 mL), 
recrystallized from iPr2O (10 mL). Light-brown crystals. 
Mp: 145-147 °C. (Lit.14 142-145 °C) 1H NMR: 2.86-315. 
(2H, m); 3.25-3.50 (2H, m); 5.97 (1H, s); 6.97 (1H, t, J = 
7.45 Hz); 7.0-7.14 (3H, m); 7.23-7.31 (2H, m); 7.34-7.39 
(1H, m); 7.44 (1H, d, J = 8.1 Hz); 7.52 (1H, J = 7.8 Hz); 
10.74 (1H, s); 11.40 (1H, s). 13C NMR: 20.3; 41.6; 49.9; 
107.6; 111.2; 112.2; 112.6; 118.8; 119.5; 119.9; 122.1;  
122.4; 123.6; 126.9; 127.0; 127.7; 132.3; 137.1; 137.3. 
Anal. Calcd for C19H17N3: C, 79.41; H, 5.96; N, 14.62. 
Found: C, 79.43; H, 5.94, N, 14.61. 
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3-(6-Methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-
1-yl)indole (9b) 
Crystallized from n-hexane/EtoAc (9:1; 7 mL), 
recrystallized from i-Pr2O (10 mL). Light-yellow crystals. 
Mp: 224-225 °C. 1H NMR: 2.64-2.81 (2H, m); 2.93-3.02 
(1H, m); 3.13-3.23 (1H, m); 3.77 (3H, s); 5.39 (1H, s); 6.62 
(1H, dd, J = 2.5, J = 7.8 Hz); 6.87 (1H, t, J = 7.6 Hz); 6.91-
6.94 (1H, m); 7.00-7.09 (2H, m); 7.11-7.15 (1H, m); 7.35 
(2H, d, J = 8.5 Hz); 10.13 (1H, s); 10.91 (1H, s). 13C NMR: 
23.4; 42.9; 50.7; 56.3; 100.7; 108.3; 110.7; 112.2; 112.4; 
116.9; 119.2; 120.3; 121.8; 125.2; 127.3; 128.2; 131.7; 
137.4; 137.9; 153.8. Anal. Calcd for C20H19N3O: C, 75.69; 
H, 6.03; N, 13.24. Found: C, 75.70; H, 6.01, N, 13.25. 
 
3-(2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indol-1-yl)-1H-
indole-2-carboxylic acid (11a) 
 Crystallized from acetone (7 mL), recrystallized from 
acetone/MeOH (4:1; 10 mL). Beige crystals. Mp: 276-277 
°C. 1H NMR: 3.09-3.19 (1H, m); 3.20-3.25 (1H, m); 3.39-
3.47 (2H, m); 6.07 (1H, s); 6.92 (1H, d, J = 7.6 Hz); 6.99 
(1H, t, J = 7.5 Hz); 7.11-7.18 (2H, m); 7.24 (1H, d, J = 7.7 
Hz); 7.3 (1H, t, J = 7.6 Hz); 7.34 (1H, d, J = 7.6 Hz); 7.40 
(1H, s); 7.46 (1H, d, J = 8.0 Hz); 9.07 (1H, s, brs); 9.67 
(1H, s, brs); 11.45 (1H, s). 13C NMR: 19.7; 42.1; 49.1; 
106.4; 110.5; 112.5; 113.2; 118.7; 119.6; 120.0; 120.4; 
122.0; 123.7; 126.8; 128.3; 132.1; 134.5; 135.2; 
137.2;165.0. Anal. Calcd for C20H17N3O2: C, 72.49; H, 
5.17; N, 12.68. Found: C, 72.51; H, 5.18, N, 12.70. 
 
3-(6-Methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-
1-yl)-1H-indole-2-carboxylic acid (11b) 
Crystallized from acetone (8 mL) and recrystallized from 
acetone:MeOH (3:1; 10 mL). Light-yellow crystals. Mp: 
230-231 °C. 1H NMR: 2.9-2.98 (1H, m); 3.01-3.12 (1H, 
m); 3.16-3.20 (1H, m); 3.62-3.70 (1H, m); 3.76 (3H, s); 
6.14 (1H, s); 6.64-6.70 (1H, m); 6.95-6.98 (1H, m); 7.06-
7.14 (2H, m); 7.18-7.24 (2H, m); 7.46 (1H, d, J = 8.5 Hz); 
7.56-7.65 (1H, m); 10.08 (1H, s); 11.44 (1H; s); .13C NMR: 
19.8; 42.1; 49.2; 56.3; 100.9; 106.3; 110.5; 112.0; 113.1; 
113.2; 120.0; 120.4; 123.7; 127.1; 128.2; 132.2; 132.3; 
132.6; 135.2; 154.2; 165.1. Anal. Calcd for C21H19N3O3: C, 
69.79; H, 5.30; N, 11.63. Found: C, 69.81; H, 5.32, N, 
11.62. 
 
General method for the synthesis of 14 and 16 
A  mixture of 1.0 mmol 2,3,4,9-tetrahydro-1H-pyrido[3,4-
b]indole [29] (12), benzaldehyde (106 mg, 1.0 mmol) and 
1- or 2-naphthol (144 mg, 1.0 mmol)  in a 10 mL 
pressurized reaction vial was heated in a CEM Discover SP 
MW reactor at 60 °C. After a reaction time of 3 h (14), or 2 
h (15), MeOH (7 mL) was added. The crystals that 
separated out were filtered off and recrystallized. 
 
 
 
1-((3,4-Dihydro-1H-pyrido[3,4-b]indol-2(9H)-
yl)(phenyl)methyl)naphthalen-2-ol (14) 
Recrystallized from iPr2O/EtOAc (1:3; 12 mL). Beige 
crystals. Mp: 203-205 °C. 1H NMR: 2.69-2.80 (1H, m); 
2.81-2.94 (2H, m); 3.09-3.21 (1H, m); 3.59-3.67 (1H,m); 
3.70-3.82 (1H,m); 5.70 (1H, s); 6.96 (1H, t, J = 7.3 Hz); 
7.00-7.06 (1H, m); 7.12 (1H, d, J = 8.8 Hz); 7.20-7.29 (3H, 
m); 7.32-7.44 (4H, m); 7.69-7.80 (4H, m); 8.06-8.15 (1H, 
m); 10.64 (1H, s); 13.42 (1H, s, brs. 13C NMR: 21.7; 49.6; 
50.3; 69.7; 107.1; 111.9; 117.4; 118.5; 119.4; 120.5; 121.6; 
122.4; 123.4; 127.2; 127.4; 128.8; 129.1; 129.5; 129.6; 
129.7; 130.2; 132.5; 132.8; 136.8; 155.9. Anal. Calcd for 
C28H24N2O: C, 83.14; H, 5.98; N, 6.93. Found: C, 83.16; 
H, 5.99, N, 6.92. 
 
2-((3,4-Dihydro-1H-pyrido[3,4-b]indol-2(9H)-
yl)(phenyl)methyl)naphthalen-1-ol (16) 
Recrystallized from iPr2O/EtOAc (1:1; 12 mL). Beige 
crystals. Mp: 196-198 °C. 1H NMR: 2.75-2.86 (2H, m); 
2.92-2.99 (1H, m); 3.06-3.13 (1H, m); 3.76 (2H, dd, J = 
26.5, 15.0 Hz); 5.12 (1H, s); 6.98 ( 1H, t, J = 7.0 Hz); 7.04 
(1H, t, J = 7.3 Hz);  7.24-7.33 (4H, m); 7.39 (2H, dd, J = 
16.2, 8.0 Hz); 7.44-7.49 (2H, m); 7.61 (1H, d, J = 7.3); 
7.76-7.80 (1H, m); 8.14-8.19 (1H, m); 10.64 (1H, s); 12.60 
(1H, brs). 13C NMR: 21.7; 49.5; 49.8; 73.6; 107.1; 111.8; 
118.4; 119.4; 119.5; 120.5; 121.6; 122.8; 125.8; 127.0; 
127.3; 127.8; 128.1; 128.6; 128.9; 129.8; 132.6; 134.1; 
136.8; 141.8; 141.9; 152.2. Anal. Calcd for C28H24N2O: C, 
83.14; H, 5.98; N, 6.93. Found: C, 83.16; H, 5.97, N, 6.94. 
 
General method for the synthesis of 15 and 17 
A mixture of 1-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-
1-yl)naphthalen-2-ol (3a) or 2-(2,3,4,9-tetrahydro-1H-
pyrido[3,4-b]indol-1-yl)naphthalen-1-ol (6a) (50 mg, 0.16 
mmol), sodium carbonate (58 mg, 0.55 mmol) and benzyl 
bromide (40 mg, 0.23 mmol) was stirred in acetonitrile (15 
mL) in an oil bath at 70 οC for 4 h. The solvent was then 
evaporated off, 15 ml water was added to the residue and 
the solution was extracted with DCM (3 x 10 mL). The 
combined organic extracts were dried (Na2SO4) and 
concentrated in vacuum. The residue was crystallized from 
iPr2O and recrystallized. 
 
1-(2-Benzyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-
yl)naphthalen-2-ol (15) 
Recrystallized from iPr2O/EtOAc (4:1; 12 mL). Light-
brown crystals. Mp: 298-199 °C. 1H NMR: 1.25 (1H, s); 
2.61-2.74 (1H, m); 2.79-2.99 (2H, m); 3.35-3.48 (1H,m); 
3.79-3.93 (1H, m); 5.85 (1H, s); 6.89-6.97 (2H, m); 7.01-
7.17 (2H, m); 7.18-7.34 (6H, m); 7.37-7.45 (2H, m); 7.78-
7.91 (2H, m); 8.31-.42 (1H, m); 9.82 (1H, s). 13C NMR: 
21.9; 28.9; 49.9; 58.1; 112.2; 112.3; 118.2; 118.3; 119.2; 
121.3; 123.4; 127.1; 127.2; 129.1; 129.2; 129.6; 129.9; 
130.6; 130.7; 134.2; 134.5; 137.3; 138.2; 147.1; 156.0; 
157.9. Anal. Calcd for C28H24N2O: C, 83.14; H, 5.98; N, 
6.93. Found: C, 83.13; H, 5.97, N, 6.92. 
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2-(2-Benzyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-
yl)naphthalen-1-ol (17) 
Recrystallized from iPr2O/EtOAc (2:1; 10 mL). Light-
brown crystals. Mp: 179-181 °C. 1H NMR: 2.65-2.75 (1 H, 
m); 2.76-290 (2H, m); 3.20-3.25 (1H, m); 3.62 (1H, d, J = 
13.8 Hz); 4.02 (1H, J = 13.3 Hz); 5.22 (1H, s); 6.93-7.01 
(2H, m); 7.24 (1H, d, J = 7.5 Hz); 7.29-7.38 (4 H, m); 
7.39-7.45 (3H, m); 7.45-7.50 ( 3H, m); 7.85 (1H, d, J = 8.3 
Hz); 8.12 (1H, d, J = 8.2 Hz); 10.31 (1H, s). 13C NMR: 
21.1; 47.9; 58.2; 63.5; 107.8; 112.2; 118.6; 119.3; 119.4; 
121.8; 122.7; 125.5; 125.7; 127.0; 127.1; 128.2; 128.4; 
129.4; 129.5; 130.2; 133.4; 134.6; 137.4; 137.9; 153.0. 
Anal. Calcd for C28H24N2O: C, 83.14; H, 5.98; N, 6.93. 
Found: C, 83.13; H, 6.00, N, 6.94. 
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